glp-1 receptor antibody Localized GLP1 pre-internalization directs pancreatic alpha cell to beta cell communication GLP-1 Receptor Agonists as Treatments

GLP-1R blockade with the antagonist exendin(939) impaired glucose tolerance in WT mice but had no effect in Pdx1-hGLP1R:Glp1r/ mice

Pfizer terminated lotiglipron in October 2023 due to dose-dependent liver enzyme elevations, and subsequently discontinued danuglipron in April 2025 after a single case of potential drug-induced liver injury was identified in a dose-optimization study

We would be honored to meet you, and we accept most insurances.

Without understanding the nutritional component, it would be easy to assume the issue is poor programming or lack of effort

They answered all my questions and scheduled me to see a provider in less than 3 days

For more information, please refer to the individual studies cited in the manuscript